Suzhou Highfine Biotech Co Ltd (SZSE:301393) Share Price

Company Profile

Business description
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Contact
No. 32 Hongxi Road
F-12 Standard Factory Building
High-tech Zone, Jiangsu Province
Suzhou215151
CHN
T: +86 51265399366
https://www.highfine.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
428

Recommended

These are the most overvalued stocks in Berkshire Hathaway’s portfolio.

Susan Dziubinski | 25 September 2025

With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio.

Simonelle Mody | 25 September 2025

A more focused business model should benefit the company.

Mark Taylor | 25 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,079.20	17.70	0.20%
CAC 40	7,870.68	75.26	0.97%
DAX 40	23,739.47	204.64	0.87%
Dow JONES (US)	46,247.29	299.97	0.65%
FTSE 100	9,284.83	70.85	0.77%
HKSE	26,128.20	356.48	-1.35%
NASDAQ	22,484.07	99.37	0.44%
Nikkei 225	45,354.99	399.94	-0.87%
NZX 50 Index	13,111.73	42.06	-0.32%
S&P 500	6,643.70	38.98	0.59%
S&P/ASX 200	8,787.70	13.20	0.15%
SSE Composite Index	3,828.11	25.20	-0.65%